United States Probiotic IBS Supplements Market to Reach $14.63 Million by 2031 | Leading companies - The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Pvt ltd

Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" Global Probiotic IBS Supplements Market reached US$ 29.12 million in 2023 and is expected to reach US$ 48.79 million by 2031, growing with a CAGR of 7.65% during the forecast period 2024-2031." Targeted microbiome formulations for IBS relief are boosting category growth.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/probiotic-ibs-supplements-market?Prasad

United States: Recent Industry Developments

✅ In November 2025, Align Probiotic launched a "Dual Action" capsule for IBS-D (Diarrhea) The formula combines B. infantis with a herbal antispasmodic to calm the gut It offers targeted relief for a specific IBS subtype

✅ In October 2025, Culturelle introduced an "IBS Complete Support" medical food packet The product contains Human Milk Oligosaccharides (HMOs) to nourish the gut barrier It provides a clinically managed dietary option for severe IBS sufferers

✅ In September 2025, IBgard released a new combination pack with a probiotic specifically for bloating The peppermint oil and probiotic work synergistically to reduce gas and pain It addresses the most bothersome symptom of IBS

✅ In August 2025, A U.S. biotech firm received FDA clearance for a prescription probiotic for IBS-C (Constipation) The high-dose formulation increases motility in patients with chronic constipation It offers a new therapeutic option for difficult-to-treat cases

Japan: Recent Industry Developments

✅ In December 2025, Biofermin Pharmaceutical launched a new "Biofermin IBS" tablet The product is an OTC drug specifically indicated for stress-induced diarrhea and constipation It leverages the high brand trust of Biofermin in Japan

✅ In November 2025, Kobayashi Pharmaceutical released a herbal-probiotic blend for "gas-type" IBS The supplement targets the embarrassment of gas and bloating in social situations It addresses a specific anxiety of Japanese consumers

✅ In October 2025, Yakult Honsha published a study on the effects of L. casei Shirota on IBS symptoms The research showed symptom improvement in Japanese patients with moderate IBS It strengthens the clinical evidence for Yakult products in medical settings

✅ In September 2025, A Japanese gastroenterology society updated guidelines to recommend specific probiotics for IBS The guidelines provide doctors with clear evidence-based recommendations It standardizes the use of probiotics in IBS treatment in Japan

Probiotic IBS Supplements Market: Drivers
Probiotic IBS supplements are growing as targeted therapies for irritable bowel syndrome, addressing symptoms such as bloating, constipation, and abdominal discomfort. Multi-strain formulations, synbiotics, and strain-specific interventions are developed based on clinical evidence for gut microbiota modulation. Advances in encapsulation technology, delayed-release systems, and shelf-stable probiotics enhance therapeutic effectiveness and convenience.

The rising prevalence of IBS and consumer demand for natural, non-pharmaceutical interventions drive market adoption. Healthcare professionals increasingly recommend probiotic supplementation alongside lifestyle modifications. Retail expansion through pharmacies, health stores, and online platforms ensures accessibility. With growing research validating specific probiotic strains, IBS-targeted supplements are set to become a mainstream digestive health solution.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/probiotic-ibs-supplements-market?Prasad

Probiotic IBS Supplements Market: Major Players
The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Pure NSM - Nutritional Supplement Manufacturers, Inc., Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd and W

Segment Covered in the Probiotic IBS Supplements Market:
By Strain
The market is segmented into Lactobacillus 40%, Bifidobacterium 35%, Saccharomyces boulardii 15%, and others 10%. Lactobacillus dominates due to strong clinical evidence supporting its role in reducing bloating, abdominal pain, and irregular bowel movements in IBS patients. Bifidobacterium shows strong adoption for its gut microbiome balancing effects. Saccharomyces boulardii grows steadily due to anti-inflammatory benefits and suitability for IBS-related diarrhea. Increasing clinical trials and strain-specific formulations are boosting market growth.

By Form
Forms include capsules 50%, tablets 20%, powders 15%, and liquid formulations 15%. Capsules dominate due to higher probiotic stability, accurate dosage, and consumer convenience. Tablets see consistent demand for cost-effective formulations. Powders and liquids grow with rising preference for customizable doses and fast absorption. Advances in microencapsulation and shelf-stable technologies support broader adoption across formats.

By Distribution Channel
Distribution channels include pharmacies and drug stores 45%, online retail 30%, supermarkets and hypermarkets 15%, and others 10%. Pharmacies dominate due to strong consumer trust and the medically oriented nature of IBS supplements. Online retail grows rapidly driven by subscription models, specialist brands, and telehealth recommendations. Supermarkets increasingly stock general digestive wellness products, supporting mainstream adoption. Digital health and e-commerce expansion continue to drive growth.

By End-User
End-users include adults 70%, geriatric population 20%, and teens 10%. Adults dominate due to the high global prevalence of IBS among working-age individuals. Geriatric users adopt probiotic IBS supplements to manage digestive irregularities linked to aging. Teen usage grows with rising cases of stress-induced IBS symptoms. Increasing awareness of gut health and self-care supplements drives demand across all age groups.

Regional Analysis
North America - 40% Share
North America leads with 40% share due to high IBS prevalence, strong clinical adoption of probiotic solutions, and widespread availability of premium digestive health supplements. Lactobacillus and Bifidobacterium strains dominate. Online and pharmacy channels drive strong demand. Consumer focus on gut health and microbiome therapy supports long-term growth.

Europe - 30% Share
Europe holds 30% share driven by strong regulatory support for probiotic health claims and rising demand for evidence-based digestive supplements. Capsules and tablets dominate. Growing clinical research and awareness campaigns enhance adoption across major markets including Germany, the UK, and France.

Asia Pacific - 20% Share
Asia Pacific accounts for 20% share with rising cases of IBS linked to lifestyle changes, stress, and dietary shifts. Probiotic powders and capsules show high adoption in Japan, South Korea, China, and Australia. Strong e-commerce growth and expanding digestive health awareness drive market expansion.

Latin America - 6% Share
Latin America records 6% share with increasing use of digestive supplements in Brazil, Mexico, and Chile. Pharmacies lead distribution. Rising consumer awareness and digital retail penetration support moderate growth.

Middle East and Africa - 4% Share
MEA holds 4% share driven by gradual increase in digestive health supplement consumption. Urban centers in the UAE and Saudi Arabia show higher adoption of probiotic IBS supplements. Expanding modern retail and health-conscious lifestyles support market penetration.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=probiotic-ibs-supplements-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.